The First Korean Case of VEXAS Syndrome Caused by a Somatic Variant

Overview

Journal Ann Lab Med

Specialty Pathology

Date 2022 Oct 25

PMID 36281520

Authors

Jihoon G Yoon

Seungbok Lee

Sheehyun Kim

Man Jin Kim

Yoon Hwan Chang

Jin Kyun Park

Dong-Yeop Shin

Jangsup Moon

Affiliations

Soon will be listed here.

Citing Articles

Neurological manifestations in patients with VEXAS syndrome.

Bert-Marcaz C, Fortanier E, Briantais A, Faucher B, Bourguiba R, Swiader L J Neurol. 2025; 272(2):181.

PMID: 39891740 DOI: 10.1007/s00415-025-12902-x.

Implementing genomic medicine in clinical practice for adults with undiagnosed rare diseases.

Ahn J, Yoon J, Cho J, Lee S, Kim S, Kim M NPJ Genom Med. 2024; 9(1):63.

PMID: 39609445 PMC: 11604660. DOI: 10.1038/s41525-024-00449-1.

VEXAS Syndrome-Diagnostic Clues for the Dermatologist and Gaps in Our Current Understanding: A Narrative Review.

Nicholson L, Cowen E, Beck D, Ferrada M, Madigan L JID Innov. 2023; 4(1):100242.

PMID: 38130326 PMC: 10733701. DOI: 10.1016/j.xjidi.2023.100242.

Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives.

Aluri J, Cooper M Semin Immunol. 2023; 67:101761.

PMID: 37062181 PMC: 11321052. DOI: 10.1016/j.smim.2023.101761.

References

Bourbon E, Heiblig M, Valentin M, Barba T, Durel C, Lega J . Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood. 2021; 137(26):3682-3684. DOI: 10.1182/blood.2020010177. View

Stubbins R, McGinnis E, Johal B, Chen L, Wilson L, Ospina Cardona D . VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome). Haematologica. 2021; 107(4):1011-1013. PMC: 8968888. DOI: 10.3324/haematol.2021.280238. View

Kunishita Y, Kirino Y, Tsuchida N, Maeda A, Sato Y, Takase-Minegishi K . Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan. Front Immunol. 2022; 13:901063. PMC: 9234115. DOI: 10.3389/fimmu.2022.901063. View

Poulter J, Collins J, Cargo C, De Tute R, Evans P, Ospina Cardona D . Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood. 2021; 137(26):3676-3681. PMC: 8462400. DOI: 10.1182/blood.2020010286. View

Arlet J, Terrier B, Kosmider O . Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med. 2021; 384(22):2163. DOI: 10.1056/NEJMc2102124. View

Stubbins R, Cherniawsky H, Chen L, Nevill T . Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. CMAJ. 2022; 194(14):E524-E527. PMC: 9001005. DOI: 10.1503/cmaj.211770. View

Beck D, Ferrada M, Sikora K, Ombrello A, Collins J, Pei W . Somatic Mutations in and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med. 2020; 383(27):2628-2638. PMC: 7847551. DOI: 10.1056/NEJMoa2026834. View

Georgin-Lavialle S, Terrier B, Guedon A, Heiblig M, Comont T, Lazaro E . Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2021; 186(3):564-574. DOI: 10.1111/bjd.20805. View

Temple M, Duroyon E, Croizier C, Rossignol J, Huet T, Friedrich C . Atypical splice-site mutations causing VEXAS syndrome. Rheumatology (Oxford). 2021; 60(12):e435-e437. DOI: 10.1093/rheumatology/keab524. View

10.

Lotscher F, Seitz L, Simeunovic H, Sarbu A, Porret N, Feldmeyer L . Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease. Front Immunol. 2022; 12:800149. PMC: 8811255. DOI: 10.3389/fimmu.2021.800149. View